This image is not available for purchase in your country.

Immunotherapy in cancer treatment

Immunotherapy in cancer treatment

M532/0120

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

PHILIPPE PLAILLY / SCIENCE PHOTO LIBRARY PHILIPPE PLAILLY / SCIENCE PHOTO LIBRARY

Caption

Immunotherapy in cancer treatment: use of a syringe to remove purified lymphocytes from a blood bag, prior to doping with Interleukin-2 (IL- 2). IL-2 is released naturally by certain key cells of the immune system (T-lymphocytes) after they have been activated by foreign antigens - of cancer cells, for instance. IL-2 amplifies the proliferation of other cell types, including lymphokine-activated killer (LAK) cells that attack cancer cells directly. Blood samples removed from a cancer victim are purified, the lymphocytes doped with IL-2 & cultured to boost the population of LAK cells. The product is then re-injected into the patient. Photographed at Centre Lyon Berard, Lyon, France, 1988/89.

Release details

Model release not required. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}